Literature DB >> 22098067

The currently used commercial DNA-extraction methods give different results of clostridial and actinobacterial populations derived from human fecal samples.

Johanna Maukonen1, Catarina Simões, Maria Saarela.   

Abstract

Recently several human health-related microbiota studies have had partly contradictory results. As some differences may be explained by methodologies applied, we evaluated how different storage conditions and commonly used DNA-extraction kits affect bacterial composition, diversity, and numbers of human fecal microbiota. According to our results, the DNA-extraction did not affect the diversity, composition, or quantity of Bacteroides spp., whereas after a week's storage at -20 °C, the numbers of Bacteroides spp. were 1.6-2.5 log units lower (P < 0.05). Furthermore, the numbers of predominant bacteria, Eubacterium rectale (Erec)-group, Clostridium leptum group, bifidobacteria, and Atopobium group were 0.5-4 log units higher (P < 0.05) after mechanical DNA-extraction as detected with qPCR, regardless of storage. Furthermore, the bacterial composition of Erec-group differed significantly after different DNA-extractions; after enzymatic DNA-extraction, the most prevalent genera detected were Roseburia (39% of clones) and Coprococcus (10%), whereas after mechanical DNA-extraction, the most prevalent genera were Blautia (30%), Coprococcus (13%), and Dorea (10%). According to our results, rigorous mechanical lysis enables detection of higher bacterial numbers and diversity from human fecal samples. As it was shown that the results of clostridial and actinobacterial populations are highly dependent on the DNA-extraction methods applied, the use of different DNA-extraction protocols may explain the contradictory results previously obtained.
© 2011 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22098067     DOI: 10.1111/j.1574-6941.2011.01257.x

Source DB:  PubMed          Journal:  FEMS Microbiol Ecol        ISSN: 0168-6496            Impact factor:   4.194


  53 in total

1.  Impact of a very low-energy diet on the fecal microbiota of obese individuals.

Authors:  C D Simões; J Maukonen; K P Scott; K A Virtanen; K H Pietiläinen; M Saarela
Journal:  Eur J Nutr       Date:  2013-12-31       Impact factor: 5.614

2.  Low diversity of gut microbiota in the early phase of post-bone marrow transplantation increases the risk of chronic graft-versus-host disease.

Authors:  Tatsuya Konishi; Shinsuke Kusakabe; Akihisa Hino; Kyoko Inamoto; Kota Yoshifuji; Yuko Kiridoshi; Kozue Takeshita; Satoshi Sasajima; Takashi Toya; Aiko Igarashi; Yuho Najima; Takeshi Kobayashi; Noriko Doki; Daisuke Motooka; Shota Nakamura; Masahiro Suyama; Wataru Suda; Atsushi Shiota; Koji Atarashi; Masahira Hattori; Kenya Honda; Takafumi Yokota; Kazuteru Ohashi; Hirohiko Shibayama; Kentaro Fukushima; Kazuhiko Kakihana
Journal:  Bone Marrow Transplant       Date:  2021-03-08       Impact factor: 5.483

3.  Gut Microbiota Analysis Results Are Highly Dependent on the 16S rRNA Gene Target Region, Whereas the Impact of DNA Extraction Is Minor.

Authors:  Anniina Rintala; Sami Pietilä; Eveliina Munukka; Erkki Eerola; Juha-Pekka Pursiheimo; Asta Laiho; Satu Pekkala; Pentti Huovinen
Journal:  J Biomol Tech       Date:  2017-02-28

Review 4.  Progress of analytical tools and techniques for human gut microbiome research.

Authors:  Eun-Ji Song; Eun-Sook Lee; Young-Do Nam
Journal:  J Microbiol       Date:  2018-09-28       Impact factor: 3.422

5.  Assessment of the human faecal microbiota: II. Reproducibility and associations of 16S rRNA pyrosequences.

Authors:  Roberto Flores; Jianxin Shi; Mitchell H Gail; Pawel Gajer; Jacques Ravel; James J Goedert
Journal:  Eur J Clin Invest       Date:  2012-03-03       Impact factor: 4.686

6.  Metabolome and fecal microbiota in monozygotic twin pairs discordant for weight: a Big Mac challenge.

Authors:  Isabel Bondia-Pons; Johanna Maukonen; Ismo Mattila; Aila Rissanen; Maria Saarela; Jaakko Kaprio; Antti Hakkarainen; Jesper Lundbom; Nina Lundbom; Tuulia Hyötyläinen; Kirsi H Pietiläinen; Matej Orešič
Journal:  FASEB J       Date:  2014-05-20       Impact factor: 5.191

7.  Towards standards for human fecal sample processing in metagenomic studies.

Authors:  Paul I Costea; Georg Zeller; Shinichi Sunagawa; Eric Pelletier; Adriana Alberti; Florence Levenez; Melanie Tramontano; Marja Driessen; Rajna Hercog; Ferris-Elias Jung; Jens Roat Kultima; Matthew R Hayward; Luis Pedro Coelho; Emma Allen-Vercoe; Laurie Bertrand; Michael Blaut; Jillian R M Brown; Thomas Carton; Stéphanie Cools-Portier; Michelle Daigneault; Muriel Derrien; Anne Druesne; Willem M de Vos; B Brett Finlay; Harry J Flint; Francisco Guarner; Masahira Hattori; Hans Heilig; Ruth Ann Luna; Johan van Hylckama Vlieg; Jana Junick; Ingeborg Klymiuk; Philippe Langella; Emmanuelle Le Chatelier; Volker Mai; Chaysavanh Manichanh; Jennifer C Martin; Clémentine Mery; Hidetoshi Morita; Paul W O'Toole; Céline Orvain; Kiran Raosaheb Patil; John Penders; Søren Persson; Nicolas Pons; Milena Popova; Anne Salonen; Delphine Saulnier; Karen P Scott; Bhagirath Singh; Kathleen Slezak; Patrick Veiga; James Versalovic; Liping Zhao; Erwin G Zoetendal; S Dusko Ehrlich; Joel Dore; Peer Bork
Journal:  Nat Biotechnol       Date:  2017-10-02       Impact factor: 54.908

8.  Evaluation of the Diversity of Probiotic Bacillus, Clostridium, and Bifidobacterium Using the Illumina-Based Sequencing Method.

Authors:  Zaichao Xu; Lixiang Cao; Jun Liu; Hongming Tan; Zujun Deng
Journal:  Probiotics Antimicrob Proteins       Date:  2018-12       Impact factor: 4.609

9.  Actinobacterial Flora in Feces of Healthy Cottontail Rabbits (Sylvilagus auduboni).

Authors:  Yu Zhang; Hongming Tan; Qingli Deng; Lixiang Cao
Journal:  Probiotics Antimicrob Proteins       Date:  2015-03       Impact factor: 4.609

Review 10.  Methodological issues in the study of intestinal microbiota in irritable bowel syndrome.

Authors:  Valentina Taverniti; Simone Guglielmetti
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.